Biomarin Pharmaceutical Inc Insider Profile
4 Followers
Biomarin Pharmaceutical Inc, former Ten Percent Owner at La Jolla Pharma, holds 6.67M shares in Catalyst Pharma (Ticker: CPRX), holds 4.47M shares in La Jolla Pharma (Ticker: LJPC). Most recently, Biomarin Pharmaceutical Inc Bought ― shares of Catalyst Pharma on Dec 11, 2012 for an estimated value of $3.75M.
Biomarin Pharmaceutical Inc's Trading History
| CPRXCatalyst Pharma | Dec 11, 2012 | ― | Informative Buy | 3.75M | $209.93M | |
| LJPCLa Jolla Pharma | Jun 19, 2009 | ― | Informative Sell | 1.16M | $27.78M |
You May Also Like
Biomarin Pharmaceutical Inc insider profile FAQ
What is the percentage of profitable transactions made by Biomarin Pharmaceutical Inc?
The percentage of profitable transactions made by Biomarin Pharmaceutical Inc is 100%.
What is the average return per transaction made by Biomarin Pharmaceutical Inc?
The average return per transaction made by Biomarin Pharmaceutical Inc is 200.40%.
What stocks does Biomarin Pharmaceutical Inc hold?
Biomarin Pharmaceutical Inc holds: LJPC, CPRX stocks.
What was Biomarin Pharmaceutical Inc’s latest transaction?
Biomarin Pharmaceutical Inc’s latest transaction was an Informative Buy of $3.75M.
What was Biomarin Pharmaceutical Inc's most profitable transaction?
Biomarin Pharmaceutical Inc’s most profitable transaction was an Informative Buy of CPRX stock on December 11, 2012. The return on the trade was 325.00%.
What is Biomarin Pharmaceutical Inc's role in La Jolla Pharma?
Biomarin Pharmaceutical Inc's role in La Jolla Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
